Dermatology Private Equity: Should You Sell or Stay Independent?
Dermatology private equity activity has made selling to an investor-backed platform a real option for many practice owners. Few specialties have seen as much consolidation, and owners of single-site and multi-provider practices alike may receive outreach from private equity groups or their affiliated platforms.
An offer can be flattering, but the decision to sell or stay independent affects your income, your autonomy, your partners and your patients for years. This guide walks through the trade-offs and how financing can support either path. Ownership rules and deal terms vary by state and transaction, and nothing here is legal, tax or investment advice.
How Dermatology Private Equity Deals Typically Work
In a typical transaction, a private equity group invests in a platform practice and then acquires additional practices to build scale. Because many states restrict who may own a medical practice, these deals are often structured so that a management company owned by the investors provides non-clinical services while physicians retain clinical ownership. Healthcare counsel should review how any proposed structure applies in your state.
Sellers usually receive a combination of:
- Cash at closing: paid for the portion of the practice being sold
- Rollover equity: an ownership stake in the larger platform, which may or may not produce a return later
- An employment agreement: compensation terms, often tied to productivity, and restrictive covenants
- Possible contingent payments: amounts tied to future performance, if the deal includes them
Understanding how much of the headline price is paid in cash and how much depends on future events is one of the most important parts of evaluating an offer. Our guide to dermatology equity rollover explains that piece in more detail.
Reasons Some Owners Sell to Private Equity
Owners who choose a dermatology private equity partner often cite reasons such as:
- Turning a large portion of practice value into cash before retirement
- Handing off administrative burdens like payer contracting, staffing and technology
- Access to capital for new locations, ancillaries and equipment
- Diversifying wealth that is otherwise concentrated in a single practice
- Having a succession solution when no associate is ready to buy
For a dermatologist close to retirement without an internal successor, a sale can create liquidity that might otherwise be hard to achieve.
Reasons Some Owners Stay Independent
Other owners decide that independence fits their goals better. Common considerations include:
- Clinical and operational control: decisions about staffing, scheduling, vendors and service lines stay with the physicians
- Long-term income: owners keep the practice’s profits rather than trading part of them for a payout today
- Culture: staff and patients may value a locally owned practice
- Flexibility: owners can decide later whether to sell, merge or transition to associates
- Uncertainty about rollover value: the second payout depends on the platform’s performance and a future sale
Younger owners with many working years ahead may weigh post-sale compensation carefully, since it can be lower than what they earned as owners.
Questions to Ask Before Signing a Letter of Intent
Before committing to any dermatology private equity offer, owners may want answers to questions like these:
- How are practice earnings being calculated, and which adjustments were made?
- What portion of the price is cash, rollover equity or contingent payments?
- What will my compensation be after closing, and how could it change?
- What restrictive covenants apply, and where?
- Who controls hiring, clinical protocols and capital spending?
- What happens to my associates, staff and any real estate I own?
Working with healthcare counsel, an accountant and an experienced advisor can help you compare offers on a like-for-like basis. US Medical Funding’s advisory and consulting services can help owners think through valuation and succession options.
Know What Your Practice Is Worth
Whether you sell or stay, understanding value is the starting point. Buyers generally focus on documented earnings, provider depth, payer mix, ancillary services and how dependent the practice is on any one physician. Our article on how to value a dermatology practice based on revenue and profit covers the main drivers.
An offer from a private equity group is one data point. An independent view of value can help you judge whether it reflects the practice’s earnings and growth potential.
Independent Alternatives to a Private Equity Sale
Staying independent does not mean doing nothing. Several paths may allow owners to create liquidity or plan succession while keeping the practice physician-owned.
- Selling to an associate: a planned transition where an employed dermatologist buys in over time, as outlined in our dermatology practice succession plan guide
- Partner buyouts: remaining partners finance the purchase of a departing partner’s interest, discussed in our dermatology partner buyout article
- Selling to another physician buyer: an individual dermatologist or small group acquires the practice
- Merging with peers: independent practices combine to share overhead while staying physician-owned
Each option has different tax, legal and financing implications, so owners should get professional input early.
How Financing Fits Into Either Decision
Financing often plays a role on both sides of the decision. Physician buyers acquiring a practice, associates buying in and partners funding a buyout may use SBA-backed loans or conventional practice loans, depending on the transaction, their credit and the practice’s cash flow. Eligibility and terms depend on the business, the buyer, use of proceeds, program rules and lender review, and every loan is subject to approval.
Owners who stay independent may also use financing to fund growth that a private equity partner would otherwise provide, such as new locations, a Mohs suite, cosmetic services or refinancing existing debt.
Timing the Decision
There is rarely a perfect moment to sell. Owners often benefit from preparing well before they intend to exit: cleaning up financial statements, reducing dependence on the owner, building an associate bench and documenting ancillary revenue. That preparation can strengthen your position whether you ultimately sell to private equity, to an associate or to another independent buyer. Our guide on how to sell a dermatology practice outlines the steps.
Final Thoughts
Dermatology private equity has given owners a meaningful exit option, but it is not the right fit for every practice. Comparing the cash, rollover equity, post-sale compensation and control you would give up against the value of staying independent can help you make a decision you will be comfortable with long after closing.
US Medical Funding helps dermatologists finance acquisitions, buy-ins, partner buyouts and growth so independent ownership remains a realistic option. Learn more about our dermatology practice financing options.
